Investigation of Antileishmanial Activities of Acridines Derivatives against Promastigotes and Amastigotes Form of Parasites Using Quantitative Structure Activity Relationship Analysis

In a search of newer and potent antileishmanial (against promastigotes and amastigotes form of parasites) drug, a series of 60 variously substituted acridines derivatives were subjected to a quantitative structure activity relationship (QSAR) analysis for studying, interpreting, and predicting activities and designing new compounds by using multiple linear regression and artificial neural network (ANN) methods. The used descriptors were computed with Gaussian 03, ACD/ChemSketch, Marvin Sketch, and ChemOffice programs. The QSAR models developed were validated according to the principles set up by the Organisation for Economic Co-operation and Development (OECD). The principal component analysis (PCA) has been used to select descriptors that show a high correlation with activities. The univariate partitioning (UP) method was used to divide the dataset into training and test sets. The multiple linear regression (MLR) method showed a correlation coefficient of 0.850 and 0.814 for antileishmanial activities against promastigotes and amastigotes forms of parasites, respectively. Internal and external validations were used to determine the statistical quality of QSAR of the two MLR models. The artificial neural network (ANN) method, considering the relevant descriptors obtained from the MLR, showed a correlation coefficient of 0.933 and 0.918 with 7-3-1 and 6-3-1 ANN models architecture for antileishmanial activities against promastigotes and amastigotes forms of parasites, respectively. The applicability domain of MLR models was investigated using simple and leverage approaches to detect outliers and outsides compounds. The effects of different descriptors in the activities were described and used to study and design new compounds with higher activities compared to the existing ones.

[1]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[2]  Walter D. Fisher On Grouping for Maximum Homogeneity , 1958 .

[3]  M. Wainwright,et al.  Acridine-a neglected antibacterial chromophore. , 2001, The Journal of antimicrobial chemotherapy.

[4]  V. Yardley,et al.  Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines. , 1997, Journal of medicinal chemistry.

[5]  M. Bouachrine,et al.  QSPR studies of 9-aniliioacridine derivatives for their DNA drug binding properties based on density functional theory using statistical methods: Model, validation and influencing factors , 2016 .

[6]  M. Bouachrine,et al.  Quantitative structure–activity relationship studies of dibenzo[a,d]cycloalkenimine derivatives for non-competitive antagonists of N-methyl-d-aspartate based on density functional theory with electronic and topological descriptors , 2015 .

[7]  S. So,et al.  Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors. , 1992, Journal of medicinal chemistry.

[8]  R. Davidson,et al.  Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  A. Basu,et al.  Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis. , 1999, The Journal of antimicrobial chemotherapy.

[10]  T. A. Andrea,et al.  Applications of neural networks in quantitative structure-activity relationships of dihydrofolate reductase inhibitors. , 1991, Journal of medicinal chemistry.

[11]  Supratik Kar,et al.  On a simple approach for determining applicability domain of QSAR models , 2015 .

[12]  F. Charmantray,et al.  Interest of acridine derivatives in the anticancer chemotherapy. , 2001, Current pharmaceutical design.

[13]  D. Gérard,et al.  Synthesis and antileishmanial activities of 4,5-di-substituted acridines as compared to their 4-mono-substituted homologues. , 2005, Bioorganic & medicinal chemistry.

[14]  W. Denny,et al.  Acridine derivatives as chemotherapeutic agents. , 2002, Current medicinal chemistry.

[15]  A. Osuna,et al.  Activity and mode of action of acridine compounds against Leishmania donovani , 1996, Antimicrobial agents and chemotherapy.

[16]  Scott D. Kahn,et al.  Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.

[17]  J. Galy,et al.  Synthesis and antileishmanial activity of 6-mono-substituted and 3,6-di-substituted acridines obtained by acylation of proflavine. , 2007, European journal of medicinal chemistry.

[18]  J. Dearden The History and Development of Quantitative Structure-Activity Relationships (QSARs) , 2016 .

[19]  J. Barbosa-Filho,et al.  A review of natural products with antileishmanial activity. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[20]  Suman Gupta,et al.  Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents. , 2007, Bioorganic & medicinal chemistry letters.

[21]  E. Pugh,et al.  An Emerging Peri-Urban Pattern of Infection with Leishmania chagasi, the Protozoan Causing Visceral Leishmaniasis in Northeast Brazil , 2004, Scandinavian journal of infectious diseases.

[22]  P. Desjeux The increase in risk factors for leishmaniasis worldwide. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  S. Croft,et al.  Natural Products as potential antiparasitic drugs. , 2002 .

[24]  J. Dearden,et al.  How not to develop a quantitative structure–activity or structure–property relationship (QSAR/QSPR) , 2009, SAR and QSAR in environmental research.

[25]  J. Galy,et al.  In Vitro Activities of 7-Substituted 9-Chloro and 9-Amino-2-Methoxyacridines and Their Bis- and Tetra-Acridine Complexes against Leishmania infantum , 2003, Antimicrobial Agents and Chemotherapy.

[26]  Gustavo E. A. P. A. Batista,et al.  How k-nearest neighbor parameters affect its performance , 2009 .

[27]  K. Roy,et al.  Be aware of error measures. Further studies on validation of predictive QSAR models , 2016 .

[28]  T. Powledge Is obesity an infectious disease? , 2004, The Lancet. Infectious diseases.

[29]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[30]  D. Marks,et al.  Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines. , 2000, Journal of medicinal chemistry.

[31]  David E. Booth,et al.  Chemometrics: Data Analysis for the Laboratory and Chemical Plant , 2004, Technometrics.

[32]  B. Tekwani,et al.  Antileishmanial, antiplasmodial and cytotoxic activities of 12,16‐dideoxy aegyptinone B from Zhumeria majdae Rech.f. & Wendelbo , 2008, Phytotherapy research : PTR.

[33]  M. Yadav,et al.  Antileishmanial Agents: An Updated Review , 2011 .